| Primary information |
|---|
| sequence ID | Seq_4257 |
| Peptide sequence | KLPGGSYMAK |
| CancerPDF_ID | CancerPDF_ID11780, CancerPDF_ID12656, |
| PMID | 26992070,26992070 |
| Protein Name | "HLA class II histocompatibility antigen, DR beta 5 chain","HLA class II histocompatibility antigen, DR beta 5 chain" |
| UniprotKB Entry Name | DRB5_HUMAN,GIMA4_HUMAN |
| Fluid | Serum,Serum |
| M/Z | NA,NA |
| Charge | NA,NA |
| Mass (in Da) | 1051.564012,1067.553392 |
| fdr | NA,NA |
| Profiling Technique | LC-MS,LC-MS |
| Peptide Identification technique | LC-MS/MS,LC-MS/MS |
| Quantification Technique | NA,NA |
| Labelled/Label Free | Label Free,Label Free |
| FDR | FDR 1 %,FDR 1 % |
| CancerPDF_ID | CancerPDF_ID11780, CancerPDF_ID12656, |
| p-Value | NA,NA |
| Software | SEQUEST and Maxquant,"Maxquant,Proteome Discoverer" |
| Length | 10,10 |
| Cancer Type | Melanoma,Melanoma |
| Database | SwissProt Database,SwissProt Database |
| Modification | NA,NA |
| Number of Patients | 8 cancer samples and 4 healthy samples,8 cancer samples and 4 healthy samples |
| Regulation | "Present in 4 cancer samples out of 8 cancer samples. ,Present in 1 healthy samples out of 4 healthy samples.","Present in 4 cancer samples out of 8 cancer samples. ,Present in 1 healthy samples out of 4 healthy samples." |
| Validation | na,NA |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | NA |
| IEDB | 438686
|